Standex International (SXI)
NYSE:SXI
Top Page
Standex International
(NYSE:SXI)
Select Model
Select Model
Rating:68Neutral
Price Target:
$268.00
▲(4.88% Upside)
Action:DowngradedDate:01/30/26
The score is driven primarily by steady financial performance and a supportive uptrend with constructive momentum. Positive earnings-call guidance and order strength add support, but the overall rating is held back by a rich valuation (high P/E) and some ongoing profitability/segment and debt-related risks.
Positive Factors
New product pipeline & fast‑growth markets
A growing new‑product pipeline and concentrated push into fast‑growth end markets create a multi‑quarter structural revenue tailwind. This supports durable organic growth, diversifies revenue mix, and increases addressable markets while enabling higher ASPs and better customer lock‑in over time.
Negative Factors
Elevated absolute debt and interest burden
Substantial outstanding debt creates persistent interest expense and constrains flexibility for opportunistic investments or aggressive buybacks. Even with gradual paydown, elevated leverage raises refinancing and macro sensitivity risks that could pressure margins and cash available for growth.
Read all positive and negative factors
Positive Factors
Negative Factors
New product pipeline & fast‑growth markets
A growing new‑product pipeline and concentrated push into fast‑growth end markets create a multi‑quarter structural revenue tailwind. This supports durable organic growth, diversifies revenue mix, and increases addressable markets while enabling higher ASPs and better customer lock‑in over time.
Read all positive factors
Standex International (SXI) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$3.10B
Dividend Yield0.57%
Average Volume (3M)143.50K
Price to Earnings (P/E)308.6
Beta (1Y)1.16
Revenue Growth18.51%
EPS Growth-28.69%
CountryUS
Employees3,700
SectorIndustrials
Sector Strength72
IndustryIndustrial - Machinery
Share Statistics
EPS (TTM)2.08
Shares Outstanding12,118,733
10 Day Avg. Volume174,098
30 Day Avg. Volume143,496
Financial Highlights & Ratios
PEG Ratio-1.36
Price to Book (P/B)2.62
Price to Sales (P/S)2.36
P/FCF Ratio45.24
Enterprise Value/Market Cap1.17
Enterprise Value/Revenue4.17
Enterprise Value/Gross Profit10.43
Enterprise Value/Ebitda23.19
Forecast
1Y Price Target
$281.33Price Target Upside10.10% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)8.86
Revenue Forecast (FY)$905.87M
Standex International Business Overview & Revenue Model
Company Description
Standex International Corporation, together with subsidiaries, manufactures and sells various products and services for commercial and industrial markets in the United States and internationally. It operates through five segments: Electronics, Eng...
How the Company Makes Money
Standex International generates revenue through multiple key streams across its diverse business segments. The Food Service segment earns money by selling commercial cooking, refrigeration, and food warming equipment to restaurants, hotels, and fo...
Standex International Earnings Call Summary
Earnings Call Date:Jan 29, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:Apr 30, 2026
Earnings Call Sentiment Positive
The call emphasized clear inflection in growth: record orders, double‑digit segment growth (notably Electronics), stronger margins, improved free cash flow and continued investment in new products and fast‑growth end markets (grid, defense, space). Offsetting items include concentrated segment weaknesses (Specialty Solutions, Scientific organically), timing variability in Engineering Technologies, a sizeable purchase‑accounting adjustment related to the Narayan minority stake, and substantial outstanding debt/ongoing capacity investments that could temper near‑term margin expansion. On balance the progress in core growth drivers and improved cash generation outweigh the challenges, though execution and macro timing remain watch items.Positive Updates
Strong Consolidated Revenue Growth and Record Orders
Total revenue increased 16.6% year‑over‑year to $221.3M; organic growth was 6.4%. Quarterly orders were approximately $231M — the highest ever — and overall book‑to‑bill was 1.04.
Negative Updates
Specialty Solutions Revenue and Margin Decline
Specialty Solutions revenue decreased 7.2% YoY to $19.8M and operating margin fell ~600 bps to 10.7%, driven by weak North American end markets; segment expects sequential improvement but near‑term pressure remains.
Read all updates
Q2-2026 Updates
Positive
Negative
Strong Consolidated Revenue Growth and Record Orders
Total revenue increased 16.6% year‑over‑year to $221.3M; organic growth was 6.4%. Quarterly orders were approximately $231M — the highest ever — and overall book‑to‑bill was 1.04.
Read all positive updates
Company Guidance
Standex reiterated its fiscal 2026 sales outlook, expecting revenue to grow by more than $110 million versus 2025, driven by new product sales (now forecast at $85 million, up from $78 million, contributing ~300 basis points of incremental growth) and fast‑growth markets (expected to grow over 45% YoY and exceed $270 million); the company launched 4 new products in Q2 (9 to date) and plans >15 for FY2026. For Q3 management expects mid‑ to high‑single‑digit organic growth year‑over‑year and slightly to moderately higher revenue sequentially, with slightly higher adjusted operating margin (Q2 adjusted operating margin was 19%, up 30 bps YoY; adjusted gross margin 42.1%, up 120 bps). Liquidity is ~$213 million, net debt $437.7 million (net leverage 2.3x after ~$10 million debt paydown in Q2), long‑term debt $534.7 million, cash $97 million; FY2026 capex is expected to be $33–38 million and Q3 interest expense $7.0–7.5 million.Standex International Financial Statement Overview
Summary
Income Statement
75
Positive
Balance Sheet
70
Positive
Cash Flow
68
Positive
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 868.58M | 790.11M | 720.63M | 741.05M | 735.34M | 656.23M |
| Gross Profit | 347.31M | 300.64M | 282.00M | 285.10M | 269.95M | 241.26M |
| EBITDA | 156.26M | 128.18M | 121.92M | 141.85M | 129.71M | 111.44M |
| Net Income | 53.88M | 55.76M | 73.07M | 138.99M | 61.39M | 36.47M |
Balance Sheet | ||||||
| Total Assets | 1.55B | 1.57B | 1.01B | 1.02B | 934.44M | 962.22M |
| Cash, Cash Equivalents and Short-Term Investments | 97.00M | 104.54M | 154.20M | 195.71M | 104.84M | 136.37M |
| Total Debt | 623.47M | 603.70M | 187.89M | 207.25M | 214.08M | 236.46M |
| Total Liabilities | 809.75M | 827.29M | 383.55M | 417.48M | 435.10M | 455.80M |
| Stockholders Equity | 700.24M | 711.68M | 621.50M | 607.45M | 499.34M | 506.43M |
Cash Flow | ||||||
| Free Cash Flow | 51.59M | 41.25M | 72.36M | 66.53M | 53.83M | 61.83M |
| Operating Cash Flow | 80.33M | 69.60M | 92.66M | 90.80M | 77.72M | 83.58M |
| Investing Cash Flow | -88.08M | -503.43M | -61.63M | 41.56M | -31.04M | -39.09M |
| Financing Cash Flow | -19.69M | 380.49M | -69.20M | -40.04M | -69.43M | -31.73M |
Standex International Technical Analysis
Positive
255.52
Price Trends
252.88
Positive
242.99
Positive
217.39
Positive
Market Momentum
1.23
Positive
54.38
Neutral
59.78
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SXI, the sentiment is Positive. The current price of 255.52 is below the 20-day moving average (MA) of 257.98, above the 50-day MA of 252.88, and above the 200-day MA of 217.39, indicating a bullish trend. The MACD of 1.23 indicates Positive momentum. The RSI at 54.38 is Neutral, neither overbought nor oversold. The STOCH value of 59.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SXI.
Standex International Risk Analysis
Standex International disclosed 26 risk factors in its most recent earnings report. Standex International reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Standex International Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $3.10B | 308.57 | 7.68% | 0.57% | 18.51% | -28.69% | |
67 Neutral | $2.17B | 37.53 | 3.75% | 0.64% | -1.46% | -10.03% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
53 Neutral | $1.82B | 32.79 | 21.10% | 0.10% | 3.91% | 1.48% | |
52 Neutral | $1.34B | -0.73 | -54.42% | ― | 11.57% | -1016.39% | |
50 Neutral | $2.12B | -48.93 | -21.90% | ― | 22.40% | -18.99% |
* Industrials Sector Average
SXI
Standex International
255.52
89.03
53.47%
EPAC
Enerpac Tool Group
34.54
-11.63
-25.19%
ENOV
Enovis
23.37
-15.51
-39.89%
HLIO
Helios Technologies
65.69
31.96
94.78%
XMTR
Xometry
40.98
14.38
54.06%
Standex International Corporate Events
Executive/Board ChangesShareholder Meetings
Standex International Holds Annual Stockholders Meeting
Neutral
Oct 31, 2025
Standex International held its Annual Meeting of Stockholders on October 21, 2025, with 11,304,234 common shares represented. During the meeting, stockholders voted to elect two directors, Thomas E. Chorman and Andy L. Nemeth, to three-year terms ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.